The genesis of a small molecule drug is often an international affair. The medication might begin its life at an active pharmaceutical ingredient (API) manufacturing facility in Puerto Rico, then stop ...

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...

What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port ...

In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...

As 2026 approaches, rising complexity, geopolitical pressures and new modalities are reshaping strategy, capacity and CDMO ...

The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...

This investment comes as LGM Pharma experiences sustained growth in prescription drug projects, including 505(b)(2) and Abbreviated New Drug Application (ANDA) programs. The Rosenberg facility ...

Key opportunities in the Global API CDMO Market include expanding pharmaceutical R&D, rising demand for complex therapies, ...

DynoChem Platform Designed to Facilitate API Process Development and Scale-up Already used by 11 of the world’s biggest pharmaceutical companies, the DynoChem (www.scale-up.com) platform was developed ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

HRV Global Life Sciences (HRV Pharma), India’s first integrated Virtual API and Pharmtech company, announced a unique, comprehensive, multi-year contract development & manufacturing (CDMO) partnership ...